Development of Multi-drug Resistance to Anticancer Drugs in HepG2 Cells Due to MRP2 Upregulation on Exposure to Menthol

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Sep 21

PMID 37733713

Authors

Katsuhito Nagai

Mayuko Tamura

Ryuga Murayama

Shuhei Fukuno

Takuya Ito

Hiroki Konishi

Affiliations

Soon will be listed here.

Abstract

Background: Menthol exerts relaxing, antibacterial, and anti-inflammatory activities, and is marketed as a functional food and therapeutic drug.

Aim: In the present study, the effects of menthol on the expression of multidrug resistance associated protein 2 (MRP2) and its association with the cytotoxicity of epirubicin (EPI) and cisplatin (CIS) were examined using HepG2 cells.

Methods: The expression levels of target genes were examined by real-time PCR. The intracellular concentration of incorporated EPI was measured by high-performance liquid chromatography. Cell viability was evaluated by MTT analysis.

Results: The expression of MRP2 mRNA was increased by exposing HepG2 cells to menthol for 24 hr. Consistent with a previous report suggesting an inverse correlation between MRP2 and Akt behavior, increased expression of MRP2 was also observed on suppression of the Akt function. Intracellular accumulation of EPI was significantly decreased by exposure of HepG2 cells to menthol, and a significant decrease in the intracellular concentration of EPI remaining was observed in HepG2 cells exposed to menthol. The decreased intracellular accumulation of EPI was significantly suppressed by treatment with MK-571, but not verapamil. Both EPI and CIS exerted cytocidal effects on HepG2 cells, but the decrease in cell viability was significantly attenuated by 24-hr menthol pre-exposure.

Conclusion: These results demonstrate that menthol causes hepatocellular carcinoma to acquire resistance to anticancer drugs such as EPI and CIS by MRP2 induction.

Citing Articles

Modulation of Multidrug Resistance Transporters by Food Components and Dietary Supplements: Implications for Cancer Therapy Efficacy and Safety.

Brodzicka A, Galanty A, Pasko P Curr Issues Mol Biol. 2024; 46(9):9686-9706.

PMID: 39329928 PMC: 11430623. DOI: 10.3390/cimb46090576.

Comparative Cytotoxicity of Menthol and Eucalyptol: An In Vitro Study on Human Gingival Fibroblasts.

Puig-Herreros C, Sanz J, Garcia-Bernal D, Rodriguez-Lozano F, Murcia L, Forner L Pharmaceutics. 2024; 16(4).

PMID: 38675182 PMC: 11054097. DOI: 10.3390/pharmaceutics16040521.

References

Lin G, Ting H, Tseng T, Juang V, Lo Y . Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells. PLoS One. 2017; 12(10):e0185625. PMC: 5624618. DOI: 10.1371/journal.pone.0185625. View

Hipfner D, Deeley R, Cole S . Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta. 1999; 1461(2):359-76. DOI: 10.1016/s0005-2736(99)00168-6. View

Lo Y, Wang W . Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem Biol Interact. 2013; 205(3):188-97. DOI: 10.1016/j.cbi.2013.07.003. View

Grant C, Valdimarsson G, Hipfner D, Almquist K, Cole S, Deeley R . Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 1994; 54(2):357-61. View

Chu T, Chan H, Hu T, Wang E, Ma Y, Huang S . Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats. Cancer Med. 2018; 7(6):2567-2580. PMC: 6010827. DOI: 10.1002/cam4.1487. View

Niizeki T, Iwamoto H, Shirono T, Shimose S, Nakano M, Okamura S . Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion. Cancers (Basel). 2021; 13(17). PMC: 8431395. DOI: 10.3390/cancers13174450. View

Tsuji K, Wang Y, Takanashi M, Odajima T, Lee G, Sugimori H . Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia. Hematol Rep. 2012; 4(3):e18. PMC: 3475940. DOI: 10.4081/hr.2012.e18. View

Du J, Liu D, Zhang X, Zhou A, Su Y, He D . Menthol protects dopaminergic neurons against inflammation-mediated damage in lipopolysaccharide (LPS)-Evoked model of Parkinson's disease. Int Immunopharmacol. 2020; 85:106679. DOI: 10.1016/j.intimp.2020.106679. View

Nies A, Konig J, Pfannschmidt M, Klar E, Hofmann W, Keppler D . Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer. 2001; 94(4):492-9. DOI: 10.1002/ijc.1498. View

10.

Juang V, Lee H, Lin A, Lo Y . Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells. Int J Nanomedicine. 2016; 11:6047-6064. PMC: 5117904. DOI: 10.2147/IJN.S117618. View

11.

Pirotta M . Irritable bowel syndrome - The role of complementary medicines in treatment. Aust Fam Physician. 2010; 38(12):966-8. View

12.

Finn R . Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition. Liver Cancer. 2013; 1(3-4):247-56. PMC: 3760459. DOI: 10.1159/000343839. View

13.

Mascher H, Kikuta C, Schiel H . Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil. Arzneimittelforschung. 2001; 51(6):465-9. DOI: 10.1055/s-0031-1300064. View

14.

Kool M, de Haas M, Scheffer G, Scheper R, Van Eijk M, Juijn J . Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997; 57(16):3537-47. View

15.

Liu K, Song J, Yan Y, Zou K, Che Y, Wang B . Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway. Transl Oncol. 2020; 14(1):100876. PMC: 7527585. DOI: 10.1016/j.tranon.2020.100876. View

16.

Liedert B, Materna V, Schadendorf D, Thomale J, Lage H . Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin. J Invest Dermatol. 2003; 121(1):172-6. DOI: 10.1046/j.1523-1747.2003.12313.x. View

17.

Borst P, Evers R, Kool M, Wijnholds J . The multidrug resistance protein family. Biochim Biophys Acta. 1999; 1461(2):347-57. DOI: 10.1016/s0005-2736(99)00167-4. View

18.

Zhang L, Yang A, Wang M, Liu W, Wang C, Xie X . Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells. Apoptosis. 2016; 21(4):473-88. PMC: 4915730. DOI: 10.1007/s10495-016-1214-9. View

19.

Nagai K, Fukuno S, Shiota M, Tamura M, Yabumoto S, Konishi H . Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells. Anticancer Res. 2021; 41(12):6105-6112. DOI: 10.21873/anticanres.15430. View

20.

Nagai K, Fukuno S, Miura T, Uchino Y, Sehara N, Konishi H . Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein. Pharmazie. 2020; 75(10):510-511. DOI: 10.1691/ph.2020.0448. View